UK and US. It is working towards a supply chain to ensure global access and has received manufacturing capacity for two billion of the vaccine’s doses to date.
Our parent business intelligence companyAstraZeneca CEO Pascal Soriot said: “We are working tirelessly to honour our commitment to ensure broad and equitable access to Oxford’s vaccine across the globe and at no profit.“Today marks an important step in helping us supply hundreds of millions of people around the world, including those in countries with the lowest means.” As part of the latest agreement, CEPI will be responsible for development and manufacturing while Gavi will focus on procurement within the global mechanism. How optimistic are you about your company’s growth